JP2011517447A5 - - Google Patents

Download PDF

Info

Publication number
JP2011517447A5
JP2011517447A5 JP2011501758A JP2011501758A JP2011517447A5 JP 2011517447 A5 JP2011517447 A5 JP 2011517447A5 JP 2011501758 A JP2011501758 A JP 2011501758A JP 2011501758 A JP2011501758 A JP 2011501758A JP 2011517447 A5 JP2011517447 A5 JP 2011517447A5
Authority
JP
Japan
Prior art keywords
antibody
amino acid
seq
acid residues
variable domain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011501758A
Other languages
English (en)
Japanese (ja)
Other versions
JP5823858B2 (ja
JP2011517447A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/011620 external-priority patent/WO2009120178A1/en
Publication of JP2011517447A publication Critical patent/JP2011517447A/ja
Publication of JP2011517447A5 publication Critical patent/JP2011517447A5/ja
Application granted granted Critical
Publication of JP5823858B2 publication Critical patent/JP5823858B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011501758A 2008-03-26 2008-10-08 抗vegf抗体 Active JP5823858B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3971908P 2008-03-26 2008-03-26
US61/039,719 2008-03-26
PCT/US2008/011620 WO2009120178A1 (en) 2008-03-26 2008-10-08 Anti-vegf antibody

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014102751A Division JP2014205674A (ja) 2008-03-26 2014-05-16 抗vegf抗体

Publications (3)

Publication Number Publication Date
JP2011517447A JP2011517447A (ja) 2011-06-09
JP2011517447A5 true JP2011517447A5 (https=) 2011-11-24
JP5823858B2 JP5823858B2 (ja) 2015-11-25

Family

ID=41114205

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2011501758A Active JP5823858B2 (ja) 2008-03-26 2008-10-08 抗vegf抗体
JP2014102751A Pending JP2014205674A (ja) 2008-03-26 2014-05-16 抗vegf抗体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014102751A Pending JP2014205674A (ja) 2008-03-26 2014-05-16 抗vegf抗体

Country Status (9)

Country Link
US (2) US7803371B2 (https=)
EP (1) EP2259795B1 (https=)
JP (2) JP5823858B2 (https=)
KR (1) KR101581244B1 (https=)
CN (2) CN102065888B (https=)
AU (1) AU2008353479B2 (https=)
BR (1) BRPI0822556B1 (https=)
CA (3) CA2981887C (https=)
WO (1) WO2009120178A1 (https=)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT3216803T (lt) 2008-06-25 2020-06-10 Novartis Ag Stabilūs ir tirpūs antikūnai, slopinantys vegf
CN102002104A (zh) 2009-08-28 2011-04-06 江苏先声药物研究有限公司 一种抗vegf的单克隆抗体及含有该抗体的药物组合物
CA2778084A1 (en) * 2009-10-23 2011-04-28 Garvan Institute Of Medical Research Modified variable domain molecules and methods for producing and using same
KR20140043724A (ko) * 2011-03-03 2014-04-10 아펙시젠, 인코포레이티드 항-il-6 수용체 항체 및 사용 방법
CN104650229A (zh) * 2011-11-02 2015-05-27 埃派斯进有限公司 抗-kdr抗体和使用方法
CN103417964A (zh) * 2012-05-17 2013-12-04 江苏先声药物研究有限公司 一种抗vegf抗体的用途
CN103417965B (zh) * 2012-05-17 2018-04-13 江苏先声药业有限公司 一种含有抗vegf抗体的药物组合物
PT2956476T (pt) 2013-02-18 2020-02-21 Vegenics Pty Ltd Moléculas de ligação e usos destas
JP2016530244A (ja) * 2013-12-31 2016-09-29 ディベロップメント センター フォー バイオテクノロジーDevelopment Center For Biotechnology 抗vegf抗体及びその使用
US9840553B2 (en) 2014-06-28 2017-12-12 Kodiak Sciences Inc. Dual PDGF/VEGF antagonists
GB201412658D0 (en) 2014-07-16 2014-08-27 Ucb Biopharma Sprl Molecules
MX2017009253A (es) * 2015-01-16 2017-10-12 Alder Biopharmaceuticals Inc Anticuerpos antiglicoproteina y usos de los mismos.
CA2991264C (en) * 2015-07-06 2023-10-10 Ucb Biopharma Sprl Tau-binding antibodies
GB201601073D0 (en) 2016-01-20 2016-03-02 Ucb Biopharma Sprl Antibodies
GB201601077D0 (en) 2016-01-20 2016-03-02 Ucb Biopharma Sprl Antibody molecule
GB201521382D0 (en) 2015-12-03 2016-01-20 Ucb Biopharma Sprl Antibodies
GB201521389D0 (en) 2015-12-03 2016-01-20 Ucb Biopharma Sprl Method
KR102799807B1 (ko) 2015-12-30 2025-04-24 코디악 사이언시스 인코포레이티드 항체 및 이의 접합체
MX2020009152A (es) 2018-03-02 2020-11-09 Kodiak Sciences Inc Anticuerpos de il-6 y constructos de fusion y conjugados de los mismos.
EP4028417A4 (en) * 2019-09-13 2024-01-24 Admare Therapeutics Society ANTI-ONCOLYTIC VIRUS ANTIGEN ANTIBODIES AND METHOD OF USE THEREOF
CA3157509A1 (en) 2019-10-10 2021-04-15 Kodiak Sciences Inc. Methods of treating an eye disorder
CN120769866A (zh) * 2022-12-29 2025-10-10 Ltz治疗股份有限公司 抗CD79b抗体及其用途
CN118344476B (zh) * 2024-05-16 2024-11-15 武汉爱博泰克生物科技有限公司 人c反应蛋白单克隆抗体、抗体对和检测试剂或试剂盒及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1179541B1 (en) * 1999-04-28 2004-06-16 Board Of Regents, The University Of Texas System Compositions and methods for cancer treatment by selectively inhibiting VEGF
CN1299833A (zh) * 1999-12-30 2001-06-20 华西医科大学口腔医学研究所 抗人血管内皮生长因子单链抗体及其制备方法
US20040185040A1 (en) 2001-11-21 2004-09-23 Celltech R & D Limited Modulating immune responses
AU2003264009A1 (en) * 2002-08-15 2004-03-03 Epitomics, Inc. Humanized rabbit antibodies
EP1651659A4 (en) * 2003-08-07 2008-09-17 Epitomics Inc METHOD FOR HUMANIZATION OF MONOCLONAL RABBIT ANTIBODIES
US7462697B2 (en) 2004-11-08 2008-12-09 Epitomics, Inc. Methods for antibody engineering
US7431927B2 (en) 2005-03-24 2008-10-07 Epitomics, Inc. TNFα-neutralizing antibodies
CN104004094B (zh) * 2008-06-25 2017-09-22 艾斯巴技术-诺华有限责任公司 使用通用抗体构架进行的兔抗体的人源化
CN102002104A (zh) * 2009-08-28 2011-04-06 江苏先声药物研究有限公司 一种抗vegf的单克隆抗体及含有该抗体的药物组合物

Similar Documents

Publication Publication Date Title
JP2011517447A5 (https=)
JP2014205674A5 (https=)
JP2009225799A5 (https=)
JP2013198490A5 (https=)
JP2020079252A5 (https=)
RU2017134495A (ru) Антитела к альфа-рецептору собачьего интерлейкина-4
JP2012010714A5 (https=)
JP2015504421A5 (https=)
JP2022031635A5 (https=)
JP2011518125A5 (https=)
JP2017514461A5 (https=)
JP2014526898A5 (https=)
JP2013519364A5 (https=)
JP2011173884A5 (https=)
IL290591B1 (en) Antibody drug conjugates (adc) that bind to 191p4d12 proteins
JP2010534478A5 (https=)
JP2013538057A5 (https=)
JP2010536384A5 (https=)
RU2017114341A (ru) Антитела к pd-l1, связывающие pd-l1 собаки
JP2012525829A5 (https=)
NZ703035A (en) Anti-human respiratory syncytial virus (rsv) antibodies and methods of use
PE20081185A1 (es) Anticuerpos que se unen a interleucina 13 (il-13) humana y composiciones farmaceuticas que lo comprenden
JP2012524071A5 (https=)
JP2016516400A5 (https=)
JP2011518546A5 (https=)